This ground-breaking new treatment is leading-edge, non-invasive and drug-free. Through a special device placed on a patient’s head, eTNS uses gentle electrical signals to stimulate parts of the brain’s trigeminal nerve, combating ADHD, depression and epilepsy through stimulation.
eTNS clinical trials have shown:
• 44% reduction in symptoms of ADHD*
• 52% symptom reduction in major depression*
• 50% or more reduction in seizures in 40% of epilepsy patients*
*Per clinical trial results
Here at The London Psychiatry Centre we use the Monarch System for eTNS, a device approved in the European Union and Canada for treatment. Unfortunately the manufacturer is currently having distribution issues and as such, we are unable to get hold of these devices at present.
Treatment with eTNS is:
- Safe for patients with epilepsy
- Pain free
- Without side effects
How does eTNS work?
eTNS works through stimulating your brain’s trigeminal nerve through electrical pulses. Research has shown regular stimulation of the trigeminal nerve in this way can help to alleviate depression. This is similar to stimulation of the vagus nerve which is conducted in a few centres in the UK, such as the Advanced Intervention Service, University of Dundee. Vagus Nerve Stimulation (VNS) however is an invasive and expensive surgical procedure with complications unlike eTNS.
A small electric patch will be placed on your forehead just over your eyebrows. This patch is connected by lead wires to a compact hand-held machine that can be carried in your pocket, fixed to your belt or put next to your bed. Gentle electrical signals then stimulate your trigeminal nerve.
The device is lent to you to be taken home and used at times that are convenient to you, or alternatively at night during sleep. Most patients opt to have their stimulation therapy at night as they sleep. When the device is on, you will probably experience a slight tingling feeling – but this should not interfere with day-to-day activities or sleep.
How safe and effective is eTNS?
Developed and tested by doctors at the University of California in Los Angeles (UCLA), eTNS has been documented in numerous peer-reviewed journals. Clinical trials have demonstrated eTNS to be an effective and safe treatment for depression in patients with epilepsy. For example a key study showed an average 58% reduction of depression symptoms in patients within an 8 week treatment period.
Here at The London Psychiatry Centre, we go to great lengths to ensure the suitability of all our patients for treatment. We will thoroughly assess you and your medical history before deciding whether you are a good candidate for eTNS.
Am I likely to be a good candidate for eTNS?
Patients who come for eTNS at The London Psychiatry Centre suffer with both epilepsy and depression. They are generally people who have found that antidepressant medication has either been unsuccessful, is disagreeable in some way because of the side effects, or considered unsafe because of the status of their epilepsy.
As one of the most highly-respected private psychiatry centres in the UK, here at The London Psychiatry Centre we take great care to establish a patient’s suitability for treatment. When you come to us you will be given a thorough, in-depth consultation and assessment which includes a rigorous analysis of your symptoms and medical history. Once we have an understanding of you as a patient, we will then be able to tell you whether eTNS is suitable for you. Rest assured, you’re in good hands.
How long will eTNS treatment take?
After your initial consultation and assessment with our Head of the Resistant Mood Disorders Unit and eminent psychiatrist Dr Andy Zamar, you will be prescribed the eTNS device to take home for treatment. Your condition will be reviewed on a weekly basis or less frequently if you are not very ill. You should expect to see noticeable results within just 8 weeks.
The London Psychiatry Centre is collaborating with Dr Fergus Rugg-Gunn, from The London Epilepsy Clinics, to deliver the best level of care for our patients. If you are suffering with depression alongside epilepsy, you don’t have to simply soldier on. Epilepsy can be challenging enough without having to endure a persistent low mood.
eTNS for ADHD
Typically diagnosed in childhood, ADHD can affect up to 10% of children and 5% of adults. Inattention and hyperactivity are symptomatic of ADHD which can lead to distress or impairment depending on the severity of the disorder. eTNS treatment of ADHD is safe, non-invasive and has none of the unpleasant side effects of treatment with medication. Using neuromodulation, eTNS can significantly reduce the symptoms of ADHD. The device is small and unobtrusive and can be used whilst sleeping, making treatment painless and easy, especially for children.
eTNS for depression
Around 350 million people worldwide suffer with depression. Traditionally, invasive surgery procedures or medications have been used to treat and limit the symptoms of depression. eTNS is the first effective, non-surgical treatment for depression and is an alternative for those on medication or for those who have not had successful medication outcomes. Treatment of depression with eTNS is safe and the portability of the device means that treatment can be carried out easily by you, alongside your regular visits, in the comfort of your own home. Clinical trials have shown it to be an effective treatment, with a 52% decrease in symptom severity over an eight-week period.
eTNS for epilepsy
Epilepsy affects up to 1% or the population and is characterised by recurrent seizures. Surgery and medication are both traditional treatment options for epilepsy but can have many unwanted side effects. eTNS offers a safe, effective mode of treatment by providing cranial nerve stimulation without the need for surgery. Clinical trials have shown that eTNS can decrease the number of seizures by up to 50% after 18 weeks of treatment. Alongside your visits, the eTNS machine, which is about the size of a mobile phone, can be taken home with you to continue therapy in the comfort of your own home.